Biolase Inc Expected To Post A Loss Of 2 Cents A Share: Earnings Preview

November 26

15/03/2022 20:59

* BIOLASE Inc  BIOL.OQ   BIOL.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 23
(estimated). 
    * The Foothill Ranch California-based  company is expected
to
report  a 40.6% increase in revenue to $11.975 million from
$8.52 million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for BIOLASE Inc is for
a loss
of 2 cents per share. For the same quarter last year, the
company reported a loss of 7 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for BIOLASE Inc
is
$2​, above​ its last closing price of $0.32. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.02       -0.03      -0.02     Beat    27.3
 Jun. 30 2021  -0.05       -0.04      -0.02     Beat    53.8
 Mar. 31 2021  -0.05       -0.05      -0.06     Missed  -20​
 Dec. 31 2020  -0.04       -0.04      -0.07     Missed  -90.9
 ​​Sep.        -0.05       -0.05      -0.05     Met     6.2
 30 2020                                                
 Jun. 30 2020  -0.17       -0.17      -0.12     Beat    29.4​
 Mar. 31 2020  -0.14       -0.17      -0.11     Beat    34
 Dec. 31 2019              -0.05      -0.05     Met     0
 This summary was machine generated March 15 at 20:59 GMT.  All
figures in US dollars  unless otherwise stated